Parkview Medical Center
has earned the Joint Commission's
Gold Seal of Approval.
|
|
|
|
|
|
Acute Coronary Syndrome (ACS)
dal-Outcomes
Physicians at Parkview Medical Center are studying the effects of an investigational drug to reduce cardiovascular morbidity and mortality in people who have recently suffered a cardiac event attributed to Acute Coronary Syndrome (ACS).
This study is being conducted under the direction of Dr. Matthew Sumpter with support from the Parkview Research Division.
For more information, please contact the Clinical Research Coordinator at [719] 584 7355.
Smoke Cessation in Patients with Acute Coronary Syndrome (ACS)
ZESCA
Physicians at Parkview Medical Center are conducting a clinical trial to determine the effects of Zyban as a smoking cessation agent in people who have been recently hospitalized with Acute Coronary Syndrome.
This study is being conducted under the direction of Dr. George Gibson with support from the Parkview Research Division.
For more information, please contact the Clinical Research Coordinator at [719] 584 7355.
Acute Coronary Syndrome (ACS)
TRACER-ACS
Physicians at Parkview Medical Center are conducting a clinical trial to determine the effects of an investigational drug for the treatment of people hospitalized with Acute Coronary Syndrome (ACS).
This study is being conducted under the direction of Dr. George Gibson with support from the Parkview Research Division.
For more information, please contact the Clinical Research Coordinator at [719] 584 7355.
|
|